PACIRA BIOSCIENCES, INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PACIRA BIOSCIENCES, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-06-30 was 82.84K shares, a 17.76% decline year-over-year.
- PACIRA BIOSCIENCES, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-03-31 was 0.00 shares.
- PACIRA BIOSCIENCES, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-09-30 was 0.00 shares.
- PACIRA BIOSCIENCES, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-06-30 was 100.73K shares, a 79.62% increase year-over-year.
- PACIRA BIOSCIENCES, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2019 was 291.98K shares, a 29.83% increase from fiscal 2018.
- PACIRA BIOSCIENCES, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2018 was 224.89K shares, a 40.43% increase from fiscal 2017.
- PACIRA BIOSCIENCES, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2017 was 160.15K shares, a 54.55% increase from fiscal 2016.
- PACIRA BIOSCIENCES, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2016 was 103.62K shares, a 104.38% increase from fiscal 2015.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2026-06-30 | 82.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-04-30 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2025-06-30 | 100.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | |
| 2024-06-30 | 56.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-07 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | |
| 2023-06-30 | 50.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-03 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | |
| 2022-06-30 | 36.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-04 | |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | |
| 2021-06-30 | 31.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-04 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | 292.88K shares derived: sum of 4 quarters · filed 2020-10-30 |
| 2020-06-30 | 36.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 292.88K shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-07 | 291.98K shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 256.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | 291.98K shares 10-K · filed 2020-02-21 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 225.67K shares derived: sum of 4 quarters · filed 2019-11-08 |
| 2019-06-30 | 35.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 225.67K shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-02 | 224.89K shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-12-31 | 189.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | 224.89K shares 10-K · filed 2019-02-28 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 159.39K shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | 34.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 159.39K shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-03 | 160.15K shares derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-12-31 | 124.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | 160.15K shares 10-K · filed 2018-02-28 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 104.66K shares derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | 35.74K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 104.66K shares derived: sum of 4 quarters · filed 2017-08-02 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-04 | 103.62K shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | 68.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | 103.62K shares 10-K · filed 2017-03-01 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | 65.52K shares derived: sum of 4 quarters · filed 2016-11-02 |
| 2016-06-30 | 34.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 65.52K shares derived: sum of 4 quarters · filed 2016-08-04 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-02 | |
| 2015-12-31 | 30.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 50.70K shares 10-K · filed 2016-02-25 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | |
| 2014-12-31 | 15.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | 15.72K shares 10-K · filed 2015-02-24 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |